Standardization and HPTLC. Fingerprinting study of Poly Herbal Unani Formulation – Habb-e-Sara Khas


Standardization and HPTLC. Fingerprinting study of Poly Herbal Unani Formulation – Habb-e-Sara Khas


1Pawan Kumar Sagar*,2R.Murugeswaran, 3Rampratap Meena, 4S. Mageswari and 5P. Meera Devi Sri, 6 Shahidul Khair

1&6Drug Standardization Research Institute, (Under CCRUM, Ministry of AYUSH., Govt. of India), PLIM Campus, IInd Floor, Kamla Nehru Nagar, Ghaziabad, U.P., India., 3Central Council for Research in Unani Medicine,(Under Ministry of AYUSH., Govt. of India),61-62, Institutional Area, Janakpuri, New Delhi, India.,4,5Drug Standardization Research Unit and 2Survey of Medicinal Plants Unit, Regional Research Institute of Unani Medicines, (Under CCRUM, Ministry of AYUSH., Govt. of India), Royapuram, Chennai, T.N., India.


International Journal of Traditional and Complementary Medicine

Standardization is used to describe all measures under taken during the manufacturing process and quality control of drug assuring its reproducible quality. Most of the traditional medicine are effective but still they lack in its standard parameters. Therefore, we need to develop standard techniques to standardize and validate herbal formulations. The drug Habb-e-Sara Khas is therapeutically useful in the treatment of Sara Khas (Epilepsy and Infantile epilepsy). The drug Habb-e-Sara Khas was prepared in three different batches as per the guidelines of National Formulary of Unani Medicine(Part-VI), Present study is aimed to evaluate the pharmacopoeial standards using physico-chemical parameters; HPTLC fingerprints, quality control and assurance parameters, using WHO guideline to ascertain the quality of drug. The physico-chemical data showed that the drug contain moisture(1.89%), total ash (5.43%),acid in-soluble(1.06%), alcohol and water soluble extractive matter (19.39%) and(60.34%),pH(1% solution) (5.93),pH(10% solution)(5.67), ASSE(18.07%) and CSSE (17.43%), Bulk density of granules(0.4989) and the TLC/HPTLC finger prints showed various spots at 254nm, 366nm and visible light (V-S reagent). The quality control study revealed the absence of microbial load, aflatoxins, heavy metals and pesticide residues, The evaluated standards will very much useful for laying the phamacopoeial standards of Habb-e-Sara Khas and also in providing the quality medicine to needful human beings.


Keywords: Habb-e-Sara Khas, Physicochemical, Quality Control and Assurance parameters, TLC/ HPTLC finger printing , Poly herbal Unani formulation drug.

Free Full-text PDF


How to cite this article:
Pawan Kumar Sagar,R.Murugeswaran, Rampratap Meena, S. Mageswari and P. Meera Devi Sri,Shahidul Khair Standardization and HPTLC. Fingerprinting study of Poly Herbal Unani Formulation – Habb-e-Sara Khas.International Journal of Traditional and Complementary Medicine 2020, 5:21.


References:

1. Anonymous.,1986. Physico-chemical standards of Unani Formulations, Part-II, CCRUM, Min. of Health and Family Welfare, New Delhi: pp.27-42
2. Anonymous.,1987. Physico-chemical standards of Unani Formulations, Part-II, CCRUM, Min. of Health and Family Welfare, New Delhi: pp.9-54
3. Anonymous.,1991. Physico-chemical standards of Unani Formulations, Part-II, CCRUM, Min. of Health and Family Welfare, New Delhi: pp.15-57
4. Anonymous.,1998. Quality Control Methods for Medicinal Plant Materials. World Health Organization, Geneva: pp 25-28.
5. Anonymous.,1990. The Ayurvedic Pharmacopoeia of India, Part-I,Vol.-1,Govt. of India, Min. of Health & Family Welfare, New Delhi: pp.120-121 and 142-143.
6. Anonymous.,1997. Official Analytical Methods of the American Spice Trade Association (ASTA), Inc. 4th edn. New Jersey: pp 149-152.
7. Anonymous.,2005,Official Methods of Analysis(AOAC), International, Horwitz W, Latimer G W,18th Edn. AOAC International: Maryland,2005, chapter 3: pp10-11, chapter 10 : pp18-23 and 26,pp17.
8. Anonymous.,2007.The Unani Pharmacopoeia of India, Part-I, Vol.-I, Govt. of India, Min. of Health & Family Welfare, New Delhi: pp.5-6,17-18 and 32-33.
9. Anonymous.,2007. The Unani Pharmacopoeia of India, Part-I, Vol.-III, Govt. of India, Min. of Health & Family Welfare, New Delhi: pp.31-33.
10. Anonymous.,2007. The Unani Pharmacopeia of India, Part-I, Vol.-IV, Govt. of India, Min. of Health & Family Welfare, New Delhi: pp.49-50.
11. Anonymous., 2007.The Unani Pharmacopoeia of India, Part-I, Vol.-II, Govt. of India, Min. of Health & Family Welfare, New Delhi: pp.51-52,81-82, 89-90 and 91-92.
12. Anonymous.,2008.The Ayurvedic Pharmacopeia of India, Part-I, Vol-VI, published by Govt. of India, Ministry of Health & Family Welfare, Dept. of AYUSH. New Delhi.
13. Anonymous.,2008.The Unani Pharmacopeia of India, Part-I, Vol-V, published by Govt. of India, Ministry of Health & Family Welfare, Dept. of AYUSH. New Delhi: pp80-81.
14. Anonymous.,2009.The Unani Pharmacopeia of India, Part-I, Vol-VI, published by Govt. of India, Ministry of Health & Family Welfare, Dept. of AYUSH. New Delhi: pp31-32 ,40-41,68-69,72-73 and 88-89.
15. Anonymous.,2011.National Formulary of Unani Medicine, Part-VI,Govt. of India, Ministry of Health & Family Welfare, Dept. of AYUSH. New Delhi.
16. Bahuguna Y.,Zaidi S.,Kumar N. and Rawat K.,2014. Standardization of Polyherbal Marketed Formulation Triphala Churna, Research and Review. Journal of Pharmacognosy and Phytochemistry2 (3): pp 28-35.
17. Patel, P.M., Patel, N.M. and Goyal, R.K.,2006. Quality control of herbal products, The Indian Phamacist,5(45): pp26-30.
18. Saxena, S.C. and Yadav, R.S., 1983. A new plant extract to suppress the population of yellow fever and dengue vector Aedes aegyptii L. Current Science 52: pp 713-715.
19. Siddqui Hakim M.A.,1995.Format for the pharmacopoeial analytical standards of compound formulation, workshop on standardization of Unani drugs, 24-25th January (appendix), Central Council for Research in Unnai Medicine, New Delhi.
20. Wagner, H. and Biadi, S.,1996. Plant Drug Analysis – A Thin Layer Chromatography Atlas, Springer-Verlag, 2nd Edn., Germany.
21. Yadav P., Mahour Y. and Kumar A.,2011. Standardization and Evaluation of Herbal Drug Formulations, Journal of Advanced Laboratory Research in Biology2(4): pp 161-166.